CLINICAL_TRIALS

Clinical Trials

This guideline provides a useful reference for the branding of clinical trial materials. It will support you in producing  any materials you need in an efficient, simple and convenient way. Please note that any communication or material designed to be viewed by patients in a clinical trial should be sincere and empathetic, using as little jargon as possible. Remember that these patients, most of whom are battling serious medical conditions, and their families and/or caretakers are looking to us for help and hope.

Corporate Branding of Clinical Study Materials

Patient Materials (Phase I-IV) Corporate Branding
Pre-Consent Patient Outreach/Recruitment Materials Use Genentech and/or Roche name and logo unless
prohibited by ethics or regulatory bodies.
Consent/Post-Consent Patient Materials Use Genentech and/or Roche name and logo unless
prohibited by ethics or regulatory bodies.


Please note: These guidelines apply to clinical study tools and documentation, but not to regulatory filings.

For all study types where a bio-pharmaceutical partner is involved (including academic groups and sponsors), corporate branding may also include a partner logo, with reasonable visual separation. Please refer to the frequently asked questions (FAQs) for recommended logo placement.

This table shows the most common cases. For more study types and which brand to use, please see tab Study type.

Type Branding
Global Product Development studies with both US and ex-US sites Genentech and Roche
In this case only, use both logos, remembering that they must appear with visual separation using the “opposite corners” (with the Genentech logo at the top left and the Roche logo at the top right of format)
Global, post-marketing studies with both US and ex-US sites Genentech and Roche
In this case only, use both logos with visual separation (opposite
corners of a format).

1. Corporate Logo

The Genentech and Roche logo are placed in the white “strip”. The strip is a white band placed at the top or bottom edge of the format. It has a defined height (3x) and contains the Roche logo. In every case, the strip represents the minimum prescribed presence of the Roche brand.

2. Name

When developing a name for your trial,remember to keep patients in mind and use a name that is simple and can be easily understood by the broadest audiences.

3. Wordmark

You may also create a wordmark for your trial, namely a typographical representation of the study name. Don’t create a logo for your clinical trial. Logos are only used for product brands and corporate brands. Here's the guidance for Genentech and Roche wordmarks.

4. Imagery

You have two options when developing the visual concept for your campaign: You can create your own imagery or you can use existing material located in the appropriate corporate brand’s image library. Many people find this second option easier since the picture libraries for Roche and Genentech contain exclusive images that already comply with copyright regulations and are free to use. They are available here. Please note that if you choose to develop your own imagery, make sure you obtain the necessary copyright and confirm the purchase conditions.

Whether you choose to develop your own visual concept or use the images readily available to you, be sure to use the visual concept consistently and respect the needs, expectations, values and beliefs of your target audience.

NOTE: The images you use (photos, pictures, drawing or presentations) must never suggest or imply the safety or efficacy of an investigational drug. For further guidance, please see the Patient Recruitment Guidance Document.

5. Colours

You can develop a colour scheme for the trial that supports your visual concept. Do not use or imitate the colour scheme planned for the product post-approval, nor any of currently used marketing colour schemes for development trials.

Post-Marketing Guidelines

If the clinical trial is for an existing product brand, please do not use that product’s brand colours or other design elements. For regulatory reasons, you should only use the appropriate corporate brand guidelines when designing clinical trial communications.

Guidance

If you have further questions, please consult  Melissa Mottolo for PDG, Genentech or Roche Brand Management, depending on which corporate brand you’re using. Allow a minimum of three days to receive feedback.

clinicaltrials_p1b
Study Type Corporate Branding
Global Product Development studies with ONLY US sites Genentech
Global Product Development studies with ONLY ex-US sites Roche
gRED studies in the US and ex-US Genentech
pRED studies in the US and ex-US Roche
Global post-marketing studies with ONLY US sites Genentech
Global post-marketing studies with ONLY ex-US sites Roche
Diagnostics studies in the US and ex-US Roche
clinical_trials

Roche Tools

Media Library

Discover a wide range of images and videos about Roche and its products.

visit

Web2Publish

Download ready-to-go templates and documents for effective online and print design.

visit

Messaging Warehouse

Receive approved, guidance, messages and materials about Roche's key topics (accessible on the intranet only).

visit

Genentech Branding

Download brand guidelines, templates and discover the photo gallery.

visit

Diagnostics BrandBridge

Access the cross-BA Diagnostics marketing resource management solution for digital content management.

visit